Have to have a go a go at anyone having a go at the "Faulding...

Have to have a go a go at anyone having a go at the "Faulding Culture" .....of which Scott was part of having been there from the late 1980s until he moved on and gained further experience with other companies. The template for international expansion had been set up in the preceding decade and then there had been a successful move in setting up a USA company. If it had not been for the sell out to Mayne Nickless in the 1990s and a break up of the various divisions, I have little doubt Faulding itself would have been a major player in the era of huge growth in the generics business in the USA and elsewhere. By the way, Brian McNamee "cut his teeth" in the pharmaceutical industry at Faulding before he went to CSL.

After Mayne Nickless divested most of Faulding's parts it was really only the people and culture that carried on the Faulding culture, that is Aussies prepared to have a go. Many gained valuable experience experience with other pharma companies before coming back to Mayne Pharma to try and repeat entry into the USA.

To be fair, the timing of acquisitions and circumstances have not favoured current management's plans particularly in the generics arena. This is referring to the hit the generic industry has suffered with the Department of Justice roadblock, unimpeded overt competition from cheap Asian imported products, increased market control by distributors and no real assistance on the political front for USA based companies employing its citizens. This has resulted it some rationalisation by Mayne Pharma of its generic business, greater focus on growing the branded product range and building on its contract business. All very sensible to me.

Don't discount Faulding culture.